175 related articles for article (PubMed ID: 9869542)
1. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.
Andresen M; Dougnac A; Díaz O; Hernández G; Castillo L; Bugedo G; Alvarez M; Dagnino J
J Crit Care; 1998 Dec; 13(4):164-8. PubMed ID: 9869542
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
Gachot B; Bedos JP; Veber B; Wolff M; Regnier B
Intensive Care Med; 1995 Dec; 21(12):1027-31. PubMed ID: 8750129
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of the nitric oxide pathway in refractory septic shock].
Andresen M; Dougnac A; Hernández G; Espejo J; Castillo L; Bugedo G; Letelier LM; Dagnino J
Rev Med Chil; 1996 Apr; 124(4):442-7. PubMed ID: 9110484
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue increases myocardial function in septic shock.
Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
[TBL] [Abstract][Full Text] [Related]
6. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue administration in septic shock: a clinical trial.
Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
[TBL] [Abstract][Full Text] [Related]
8. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
[TBL] [Abstract][Full Text] [Related]
9. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.
Juffermans NP; Vervloet MG; Daemen-Gubbels CR; Binnekade JM; de Jong M; Groeneveld AB
Nitric Oxide; 2010 May; 22(4):275-80. PubMed ID: 20109575
[TBL] [Abstract][Full Text] [Related]
10. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep.
Kirov MY; Evgenov OV; Bjertnaes LJ
Crit Care Med; 2003 Jan; 31(1):179-86. PubMed ID: 12545013
[TBL] [Abstract][Full Text] [Related]
11. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.
Jolliet P; Bulpa P; Ritz M; Ricou B; Lopez J; Chevrolet JC
Crit Care Med; 1997 May; 25(5):786-94. PubMed ID: 9187597
[TBL] [Abstract][Full Text] [Related]
12. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
Mount JC; Rowe AS
Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
[TBL] [Abstract][Full Text] [Related]
13. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
[TBL] [Abstract][Full Text] [Related]
14. Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep.
Evgenov OV; Sveinbjørnsson B; Bjertnaes LJ
Acta Anaesthesiol Scand; 2001 Nov; 45(10):1246-54. PubMed ID: 11736678
[TBL] [Abstract][Full Text] [Related]
15. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics.
Walmrath D; Grimminger F; Pappert D; Knothe C; Obertacke U; Benzing A; Günther A; Schmehl T; Leuchte H; Seeger W
Eur Respir J; 2002 May; 19(5):805-10. PubMed ID: 12030717
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue for the treatment of septic shock.
Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
[TBL] [Abstract][Full Text] [Related]
17. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock.
Avontuur JA; Tutein Nolthenius RP; Buijk SL; Kanhai KJ; Bruining HA
Chest; 1998 Jun; 113(6):1640-6. PubMed ID: 9631805
[TBL] [Abstract][Full Text] [Related]
18. Prolonged methylene blue infusion in refractory septic shock: a case report.
Dumbarton TC; Minor S; Yeung CK; Green R
Can J Anaesth; 2011 Apr; 58(4):401-5. PubMed ID: 21246318
[TBL] [Abstract][Full Text] [Related]
19. High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?
Roch A; Papazian L; Bregeon F; Gainnier M; Michelet P; Thirion X; Saux P; Thomas P; Jammes Y; Auffray JP
Intensive Care Med; 2001 Nov; 27(11):1737-43. PubMed ID: 11810116
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: A randomized controlled trial.
Ismail R; Awad H; Allam R; Youssef O; Ibrahim M; Shehata B
J Neonatal Perinatal Med; 2022; 15(2):265-273. PubMed ID: 34719443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
